Jiangsu Expressway Co Ltd (0177)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 16 Oct 2026
Key indicators
| Last close | HKD 11.41 |
|---|---|
| 52-week range | 8.28 – 11.65 |
| Return, 1 month / 3 months | +9.0% / +13.3% |
| Return, 1 year / 3 years | +37.9% / +86.4% |
| Trend | Uptrend |
| RSI (14) | 72 |
| Volatility (1 year) | 21.9% |
| Worst drawdown (1 year) | -13.7% |
| Average daily value traded | 39.98M HKD |
| Dividend yield | 4.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Jiangsu Expressway operates toll roads and bridges in Jiangsu Province, China, collecting fees from drivers who use its expressway network. The company also runs service areas and provides related support facilities along its routes, serving motorists, freight operators and other road users. It is based in Nanjing and focuses on the construction, management and maintenance of highway infrastructure in its home region.
On this site Jiangsu Expressway Co Ltd appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 0177, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Jiangsu Expressway Co Ltd (0177) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 11.41 on 16 October 2026.
Its price-based Market X-Ray is 85 out of 100 (a strong price profile), ranking 26 of 3,157 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 37.9% and over the last three months it rose 13.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 16.1% | ||
| From 52-week high | -1.6% | ||
| Momentum | 82 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 13.3% | ||
| 6-month return | 15.6% | ||
| 12-month return, skipping the last month | 26.5% | ||
| Stability (higher is calmer) | 96 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.7% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 39.98M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.5% |
|---|---|
| 1 month | +9.0% |
| 3 months | +13.3% |
| 6 months | +15.6% |
| 1 year | +37.9% |
| 3 years | +86.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 10.17 / 9.82 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.29 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Jun 2026 | HKD 0.5600 |
| 3 Jul 2025 | HKD 0.5367 |
| 2 Jul 2024 | HKD 0.5153 |
| 26 Jun 2023 | HKD 0.5042 |
| 5 Jul 2022 | HKD 0.5369 |
| 21 Jun 2021 | HKD 0.5579 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.